This topic contains a solution. Click here to go to the answer

Author Question: The advantages of a limited company (corporation) do NOT include (Read 118 times)

Melani1276

  • Hero Member
  • *****
  • Posts: 516
The advantages of a limited company (corporation) do NOT include
◦ can continue indefinitely.
◦ easy to set up.
◦ business decisions made by career administrators.
◦ limited personal risk.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by Melani1276 on Nov 10, 2019

brbarasa

  • Sr. Member
  • ****
  • Posts: 308
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 29% of students answer this correctly




Melani1276

  • Member
  • Posts: 516
Reply 2 on: Nov 10, 2019
Great answer, keep it coming :)


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library